| ASSET | QUARTER | % RETURN |
|---|---|---|
AbbVie (ABBV) | Q1 2015 | -10.12% |
AbbVie (ABBV) | Q2 2015 | 15.85% |
AbbVie (ABBV) | Q3 2015 | -19.27% |
AbbVie (ABBV) | Q4 2015 | 9.34% |
AbbVie (ABBV) | Q1 2016 | -0.59% |
AbbVie (ABBV) | Q2 2016 | 10.47% |
AbbVie (ABBV) | Q3 2016 | 2.65% |
AbbVie (ABBV) | Q4 2016 | 0.28% |
AbbVie (ABBV) | Q1 2017 | 4.6% |
AbbVie (ABBV) | Q2 2017 | 12.25% |
AbbVie (ABBV) | Q3 2017 | 23.23% |
AbbVie (ABBV) | Q4 2017 | 8.52% |
AbbVie (ABBV) | Q1 2018 | -1.86% |
AbbVie (ABBV) | Q2 2018 | -0.42% |
AbbVie (ABBV) | Q3 2018 | 3.79% |
AbbVie (ABBV) | Q4 2018 | -1.65% |
AbbVie (ABBV) | Q1 2019 | -10.59% |
AbbVie (ABBV) | Q2 2019 | -9.01% |
AbbVie (ABBV) | Q3 2019 | 4.59% |
AbbVie (ABBV) | Q4 2019 | 18.37% |
AbbVie (ABBV) | Q1 2020 | -13.31% |
AbbVie (ABBV) | Q2 2020 | 38.16% |
AbbVie (ABBV) | Q3 2020 | -9.99% |
AbbVie (ABBV) | Q4 2020 | 23.18% |
AbbVie (ABBV) | Q1 2021 | 2.15% |
